After the shock of hearing the words actually
spoken- “colon cancer” or “rectal cancer”-
follows the stream of inevitable questions. How did this happen?
Will I survive? What’s next? Patients often find themselves
confused by the array of treatment decisions that must be
made quickly, while they are still dealing with the emotional
reality of their disease.
Fortunately, today patients have a greater variety of treatment
options open to them, guided by the steady progress of medical
science. Since the very earliest days of cancer research,
physician-scientists have built on the discoveries of their
predecessors to amass an ever growing body of knowledge about
Oncologists improve these treatments through controlled clinical
trials, also called clinical studies. These trials use proven
scientific methods to compare promising new drugs and technologies
against the standard of care. Besides paving the way for tomorrow’s
treatments, such studies are also an avenue for delivering
state-of-the-art care for patients today.
Clinical trials are the result of the partnership of the professor,
oncologists studying treatment advances, and the survivor.
The National Cancer Survivorship (NCCS) defines “survivor”
from the time of diagnosis to the end of one’s life,
no matter what stage of disease.
The future of curing cancer depends on clinical trials and
the special relationship between the professor and the survivor
- both full partners in the research endeavor.
Clinical Trials are research studies to
investigate new options in the fight against cancer. They
are protocols to further research into cancer treatment.
We would like to give special thanks to all cancer patients and
researchers who provide hope and help advance medical science
by participating in clinical trials.
Also, we would like to thank
Pfizer Oncology who helped make this brochure possible.
Please visit www.vitaloptions.org
for more information and links to a network of support.